152 related articles for article (PubMed ID: 38691204)
21. Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma.
Bajpai M; Pal K; Agarwala S; Seth T; Gupta AK
Pediatr Surg Int; 2005 May; 21(5):364-8. PubMed ID: 15838617
[TBL] [Abstract][Full Text] [Related]
22. Radiomics model of contrast-enhanced computed tomography for predicting the recurrence of acute pancreatitis.
Chen Y; Chen TW; Wu CQ; Lin Q; Hu R; Xie CL; Zuo HD; Wu JL; Mu QW; Fu QS; Yang GQ; Zhang XM
Eur Radiol; 2019 Aug; 29(8):4408-4417. PubMed ID: 30413966
[TBL] [Abstract][Full Text] [Related]
23. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
25. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
[TBL] [Abstract][Full Text] [Related]
26. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
[TBL] [Abstract][Full Text] [Related]
29. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study.
Wang LL; Filippi RZ; Zurakowski D; Archibald T; Vargas SO; Voss SD; Shamberger RC; Davies K; Kozakewich H; Perez-Atayde AR
Am J Surg Pathol; 2010 Mar; 34(3):287-99. PubMed ID: 20118773
[TBL] [Abstract][Full Text] [Related]
30. Advanced hepatoblastoma: successful liver resection following preoperative chemotherapy.
Choudhury SR; Singh D
Trop Gastroenterol; 2004; 25(1):32-3. PubMed ID: 15303469
[TBL] [Abstract][Full Text] [Related]
31. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
Davies JQ; de la Hall PM; Kaschula RO; Sinclair-Smith CC; Hartley P; Rode H; Millar AJ
J Pediatr Surg; 2004 Sep; 39(9):1321-7. PubMed ID: 15359384
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of Contrast-Enhanced CT-Based Deep Transfer Learning and Combined Clinical-Radiomics Model to Discriminate Thymomas and Thymic Cysts: A Multicenter Study.
Yang Y; Cheng J; Peng Z; Yi L; Lin Z; He A; Jin M; Cui C; Liu Y; Zhong Q; Zuo M
Acad Radiol; 2024 Apr; 31(4):1615-1628. PubMed ID: 37949702
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy: A case-control study.
Tang S; Ou J; Wu YP; Li R; Chen TW; Zhang XM
Medicine (Baltimore); 2021 Jul; 100(27):e26557. PubMed ID: 34232198
[TBL] [Abstract][Full Text] [Related]
34. Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience.
Tayfun Küpesiz F; Akınel AN; Akbaş H; Sivrice Ç; Tüysüz Kintrup G; Karagüzel G; Melikoğlu M; Gelen MT; Aydınlı B; Küpesiz A; Güler E
Turk J Gastroenterol; 2022 Dec; 33(12):1069-1078. PubMed ID: 36262102
[TBL] [Abstract][Full Text] [Related]
35. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
36. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
Qi W; Yang J; Zheng L; Lu Y; Liu R; Ju Y; Niu T; Wang D
Med Phys; 2023 May; 50(5):2705-2714. PubMed ID: 36841949
[TBL] [Abstract][Full Text] [Related]
37. Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma.
Lautz TB; Ben-Ami T; Tantemsapya N; Gosiengfiao Y; Superina RA
Cancer; 2011 May; 117(9):1976-83. PubMed ID: 21509775
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
Ayllon Teran D; Gómez Beltran O; Ciria Bru R; Mateos González E; Peña Rosa MJ; Luque Molina A; López Cillero P; Briceño Delgado J
World J Gastroenterol; 2014 Aug; 20(29):10137-43. PubMed ID: 25110441
[TBL] [Abstract][Full Text] [Related]
39. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
40. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
